加入收藏 您好,维百奥生物为您提供专业、专心的产品和服务!
支付方式 配送方式 售后服务 企业QQ:1877748443 电子邮箱:info@vicbio.com
咨询请直拨:136-9140-9741 / International: +86-13691409741
全国免费热线:400-001-2615
 我的询价单 会员中心
维百奥生物可提供Polymun Scientific品牌产品
2019-04-06 文章来源: 浏览量:3073 分享到:

Polymun Scientific

维百奥生物可提供Polymun Scientific品牌产品


【声明1】我司本网页所展示产品列表、Logo、图片、商标、品牌中英文名字,仅作为客观展示产品所用,如有侵权,请联系随时联系我司。

【声明2】我司不销售归类为危险品或其他违规品的产品,但由于本行业产品货号、型号众多,我司在发布时,难免遗漏,如在网页上显示某一货号或品名属于危险品或其他违规品,不代表我司倾向宣传或有意愿销售该产品;欢迎各界朋友批评指正,我们将立即改正。

【声明3】本网页所展示的品牌和产品,仅用于科学研究,不可用于人体、不可用于诊断或治疗。



Polymun Scientific是生物制药CRO及药物递送技术公司,主要提供脂质体/LNP制剂开发服务和哺乳动物细胞技术平台。Polymun的两大核心能力是利用哺乳动物细胞技术开发和生产生物制药,以及创新的脂质体/LNP药物递送平台。Polymun将该递送平台应用于mRNA、小分子、肽及蛋白质等多种药用活性成分,优化药理学活性制剂的递送效果;提供从研发到生产的全流程CRO服务及技术授权服务,支持客户项目的工业放大与成本控制。公司拥有约100名高素质科学家、技术人员及支持人员,其中50%拥有生物技术、生物学或化学等自然科学领域的学术头衔。Polymun致力于以质量和可靠性为前提,推动创新与创造力,产品与服务广泛应用于生物制药开发、基因治疗、疫苗研发及靶向药物递送等领域。

Polymun Scientific


❑ Polymun Scientific产品线

生物制药:提供rhFSH(生物类似药)、红细胞生成素(生物类似药)、HIV包膜蛋白、SGM-101抗体、人源化抗Netrin-1单克隆抗体、人源化单克隆IgG4及小鼠单克隆抗体HPC-4,覆盖生物类似药开发、传染病研究与肿瘤靶向治疗等领域。

脂质体/LNP药物制剂:涵盖编码花生过敏原的mRNA脂质纳米颗粒制剂、编码III型干扰素(ETH47)mRNA的脂质纳米颗粒制剂、Omega表观基因组控制(OEC)mRNA药物、mRNA脂质纳米颗粒制剂及脂质体佐剂WTCc,支持疫苗开发、免疫治疗与基因药物递送研究。

研发项目:包括脂质体超氧化物变异酶、重组猪胰蛋白酶、碳酰化Epo-Fc融合蛋白及HIV抗体,专注于酶替代疗法、生物制药工艺优化及传染病防治的前沿探索。

研究试剂:提供HIV抗体与HIV抗原,用于传染病免疫检测、疫苗研发及基础科研中的抗原抗体分析。


❑ Polymun Scientific产品列表

分类产品名称
BiopharmaceuticalsrhFSH (biosimilar), for in-vitro fertilization
BiopharmaceuticalsErythropoietin (biosimilar), stimulation of production of reticulocytes
BiopharmaceuticalsHIV envelope protein as self-assembling nanoparticles, HIV vaccine candidate
BiopharmaceuticalsTwo trimeric HIV envelope proteins established by University of Regensburg, HIV vaccine candidates
BiopharmaceuticalsRecombinant human soluble angiotensin converting enzyme 2 (ACE2), therapy of COVID-19 as well as various diseases with an imbalance of the renin angiotensin system
BiopharmaceuticalsSGM-101, antibody conjugated to near-infrared fluorochrome, detection of cancer during surgery for colorectal cancer or pancreatic cancer
BiopharmaceuticalsEight trimeric HIV envelope proteins, HIV vaccine
BiopharmaceuticalsHumanised anti-Netrin-1 monoclonal antibody, treatment of cancer
BiopharmaceuticalsGNbAC1, humanized monoclonal IgG4, treatment of multiple sclerosis
BiopharmaceuticalsHuman monoclonal IgG1, treatment of Hepatitis C virus (HCV) infection
BiopharmaceuticalsMurine monoclonal antibody HPC-4, affinity purification of protein C (Ceprotin®)
BiopharmaceuticalsChimeric monoclonal IgG1 against GD2, treatment of neuroblastoma
Liposomal/LNPLipid nanoparticle formulation of mRNA coding for type III interferon (ETH47)
Liposomal/LNPSaponin/MPLA nanoparticles (SMNP) developed at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT) as adjuvant for HIV candidate vaccines
Liposomal/LNPOmega Epigenomic Controller (OEC) mRNA medicine delivered by lipid nanoparticles (OTX-2002)
Liposomal/LNPLipid nanoparticle formulation of mRNA coding for Plasmodium falciparum (causative pathogen for Malaria) antigens
Liposomal/LNPLipid nanoparticle formulation of mRNA coding for Mycobacterium tuberculosis antigens
Liposomal/LNPLipid nanoparticle formulation of mRNA coding for HSV-2 antigens
Liposomal/LNPLipid nanoparticle formulation of mRNA as coronavirus vaccine
Liposomal/LNPLipid nanoparticle formulation of surface protein encoding mRNA as coronavirus vaccine
Liposomal/LNPLipid nanoparticle formulations of surface protein encoding mRNA and self-amplifying RNA as coronavirus vaccine
Liposomal/LNPPlain liposomes as carrier for mRNA for cell therapy
Liposomal/LNPLipid nanoparticle formulation of mRNA coding for a therapeutic antibody
Liposomal/LNPLiposomal formulation of curcumin for the treatment of cancer
Liposomal/LNPLipid nanoparticle formulation of self-amplifying RNA as coronavirus vaccine
Liposomal/LNPLipid nanoparticle formulation of miRNA INT-1B3 for treatment of advanced solid tumors
Liposomal/LNPLiposomal saRNA MTL-CEBPA with Smarticle technology for cancer treatment
Liposomal/LNPLiposomal miRNA MRX34 with Smarticle technology for cancer treatment
Liposomal/LNPLiposomal formulation of siRNA
Liposomal/LNPLiposomal adjuvant WTCc
Liposomal/LNPACI-24, liposomal Alzheimer’s disease vaccine with MPLA adjuvant
Liposomal/LNPLiposomal formulation of HIV membrane protein gp41 and MPLA as HIV vaccine
Liposomal/LNPLiposomal of DNAi PNT100 with Smarticle technology for cancer treatment
Liposomal/LNPLiposomal formulation of galantamine for the treatment of neuropathic pain